ID   ADRB2_MERUN             Reviewed;         251 AA.
AC   O70431;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   07-APR-2021, entry version 108.
DE   RecName: Full=Beta-2 adrenergic receptor;
DE   AltName: Full=Beta-2 adrenoreceptor;
DE            Short=Beta-2 adrenoceptor;
DE   Flags: Fragment;
GN   Name=ADRB2;
OS   Meriones unguiculatus (Mongolian jird) (Gerbillus unguiculatus).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Gerbillinae; Meriones.
OX   NCBI_TaxID=10047;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adipose tissue, Brain, and Stria vascularis;
RX   PubMed=10398761; DOI=10.1007/s002329900538;
RA   Wangemann P., Liu J., Shimozono M., Scofield M.A.;
RT   "Beta1-adrenergic receptors but not beta2-adrenergic or vasopressin
RT   receptors regulate K+ secretion in vestibular dark cells of the inner
RT   ear.";
RL   J. Membr. Biol. 170:67-77(1999).
CC   -!- FUNCTION: Beta-adrenergic receptors mediate the catecholamine-induced
CC       activation of adenylate cyclase through the action of G proteins. The
CC       beta-2-adrenergic receptor binds epinephrine with an approximately 30-
CC       fold greater affinity than it does norepinephrine (By similarity).
CC       {ECO:0000250|UniProtKB:P07550}.
CC   -!- SUBUNIT: Binds SLC9A3R1 and GPRASP1. Interacts with ARRB1 and ARRB2.
CC       Interacts with SRC, USP20 and USP33. Interacts with VHL; the
CC       interaction, which is increased on hydroxylation of ADRB2,
CC       ubiquitinates ADRB2 leading to its degradation. Interacts with EGLN3;
CC       the interaction hydroxylates ADRB2 facilitating VHL-E3 ligase-mediated
CC       ubiquitination. Interacts (via PDZ-binding motif) with SNX27 (via PDZ
CC       domain); the interaction is required when endocytosed to prevent
CC       degradation in lysosomes and promote recycling to the plasma membrane.
CC       Interacts with CNIH4. Interacts with ARRDC3.
CC       {ECO:0000250|UniProtKB:P07550}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P07550};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P07550}. Early
CC       endosome {ECO:0000250|UniProtKB:P07550}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P07550}. Note=Colocalizes with VHL at the cell
CC       membrane. Activated receptors are internalized into endosomes prior to
CC       their degradation in lysosomes. Activated receptors are also detected
CC       within the Golgi apparatus. {ECO:0000250|UniProtKB:P07550}.
CC   -!- PTM: Phosphorylated by PKA and BARK upon agonist stimulation, which
CC       mediates homologous desensitization of the receptor. PKA-mediated
CC       phosphorylation seems to facilitate phosphorylation by BARK.
CC   -!- PTM: Phosphorylation of Tyr-67 is induced by insulin and leads to
CC       supersensitization of the receptor. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Agonist-induced ubiquitination leads to sort
CC       internalized receptors to the lysosomes for degradation.
CC       Deubiquitination by USP20 and USP33, leads to ADRB2 recycling and
CC       resensitization after prolonged agonist stimulation. USP20 and USP33
CC       are constitutively associated and are dissociated immediately after
CC       agonist stimulation (By similarity). {ECO:0000250}.
CC   -!- PTM: Palmitoylated. {ECO:0000250|UniProtKB:P07550}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Adrenergic receptor subfamily. ADRB2 sub-subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF055350; AAC12768.1; -; mRNA.
DR   SMR; O70431; -.
DR   PRIDE; O70431; -.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004941; F:beta2-adrenergic receptor activity; IEA:InterPro.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; IEA:InterPro.
DR   GO; GO:1901098; P:positive regulation of autophagosome maturation; ISS:GO_Central.
DR   GO; GO:1904504; P:positive regulation of lipophagy; ISS:GO_Central.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; IEA:InterPro.
DR   InterPro; IPR000332; ADRB2_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24248:SF21; PTHR24248:SF21; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00562; ADRENRGCB2AR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Endosome; G-protein coupled receptor;
KW   Golgi apparatus; Lipoprotein; Membrane; Palmitate; Phosphoprotein;
KW   Receptor; Transducer; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           <1..>251
FT                   /note="Beta-2 adrenergic receptor"
FT                   /id="PRO_0000069132"
FT   TRANSMEM        <1..21
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        22..32
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        33..55
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        56..76
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        77..100
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        101..122
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        123..146
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        147..200
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        201..224
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        225..231
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        232..>251
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   REGION          119..133
FT                   /note="Agonist and antagonist binding"
FT                   /evidence="ECO:0000250"
FT   REGION          212..219
FT                   /note="Agonist and antagonist binding"
FT                   /evidence="ECO:0000250"
FT   REGION          238..242
FT                   /note="Agonist and antagonist binding"
FT                   /evidence="ECO:0000250"
FT   BINDING         39
FT                   /note="Agonist or antagonist"
FT                   /evidence="ECO:0000250"
FT   BINDING         44
FT                   /note="Agonist or antagonist"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         67
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   MOD_RES         172
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   MOD_RES         187
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         188
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   LIPID           191
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P07550"
FT   DISULFID        32..117
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        110..116
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   NON_TER         1
FT   NON_TER         251
SQ   SEQUENCE   251 AA;  28502 MW;  6B9A873BB804608B CRC64;
     LACAGLVMGL AVVPFGASHI LMNMWNFGNF WCEFWTSIDV LCVTASIETL CVIAVDRYIA
     ITAPFKYQSL LTKNKARVVI LMVWIVSGLT SFLPIQMHWY RATNKEAITC YTNETCCDFF
     TNQAYAIASS IVSFYVPLVV MVFVYSRVFQ VAKRQLQKID KSEGRFHAQN LSQVEQDGRS
     GHGLRRSSKF CLKEHKALKT LGIIMGTFTL CWLPFFIVNV VHAIKENLIP KEVYILLNWL
     GYVNSAFNPL I
//
